Redhill Biopharma
RDHL
#10476
Rank
A$5.98 M
Marketcap
A$1.80
Share price
1.07%
Change (1 day)
-84.61%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): A-$1,010

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is A-$1,054. In 2017 the company made an earnings per share (EPS) of A-$3,765 a decrease over its 2016 EPS that were of A-$3,313.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$1,010
2017A-$3,76513.64%
2016A-$3,3139.12%
2015A-$3,03668.01%
2014A-$1,807-25.93%
2013A-$2,440

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$5.58-100.53%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$11.44-101.08%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$5.42-100.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
A$1.84-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
A$0.95-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel